Concord Medical Services Holdings Ltd
F:C2CA
Concord Medical Services Holdings Ltd
F:C2CA
Price:
6.25
EUR
Market Closed
Market Cap:
€2.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Concord Medical Services Holdings Ltd
F:C2CA
|
CN |
|
M
|
Melco International Development Ltd
XMUN:MX7A
|
HK |
|
Oncopeptides AB
OTC:ONPPF
|
SE |
|
Tekcapital PLC
F:8T5
|
UK |
|
Corestate Capital Holding SA
F:CCAP
|
LU |
|
P
|
Purifloh Ltd
F:WXV
|
AU |
|
B
|
Bechtle AG
XBER:BC8
|
DE |
|
M
|
Mgi Digital Technology SA
SWB:2EI
|
FR |
|
G
|
Guangzhou Automobile Group Co Ltd
XMUN:02G
|
CN |
|
A
|
Acciona SA
XMUN:AJ3
|
ES |
|
A
|
Acciona SA
DUS:AJ3
|
ES |
|
S
|
Synthomer PLC
F:7YC
|
UK |
|
V
|
Victrex PLC
F:1OY
|
UK |
|
S
|
Schaeffler AG
XMUN:SHA0
|
DE |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is C2CA's stock price target?
Not Available
C2CA does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Concord Medical Services Holdings Ltd?
Projected CAGR
-38%
-38%
Over the last 14 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 6 years is -38%.
What is the Gross Profit forecast for Concord Medical Services Holdings Ltd?
Projected CAGR
7%
7%
Over the last 14 years, the compound annual growth rate for Gross Profit has been -16%. The projected CAGR for the next 12 years is 7%.
